Suzanne Williams
Overview
Explore the profile of Suzanne Williams including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
45
Citations
424
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Williams S, Keogh S, Herd D, Riggall S, Glass R, Slaughter E, et al.
J Adv Nurs
. 2025 Jan;
PMID: 39844529
Aim: To evaluate the impact of a participatory, action-oriented implementation study, guided by the integrated Promoting Action on Research Implementation in Health Services framework, for optimising pain care processes in...
2.
Gracen L, Aikebuse M, Sarraf B, McPhail S, Russell A, OBeirne J, et al.
Patient Prefer Adherence
. 2024 Sep;
18:1845-1855.
PMID: 39280346
Background: Although clinical guidelines endorse screening for metabolic dysfunction-associated steatotic liver disease (MASLD) with advanced fibrosis in people with type 2 diabetes (T2D), the feasibility of and barriers and considerations...
3.
Elvidge N, Hobbs M, Fox A, Currie J, Williams S, Theobald K, et al.
BMC Prim Care
. 2024 May;
25(1):182.
PMID: 38783189
Background/objective: Initially established to improve access to healthcare, particularly for primary care, the full potential of the nurse practitioner role is yet to be realised in most countries. Despite this,...
4.
Gracen L, Muthukumara W, Aikebuse M, Russell A, OBeirne J, Irvine K, et al.
Ann Hepatol
. 2023 Jul;
28(6):101142.
PMID: 37468097
Introduction And Objectives: Among people with type 2 diabetes (T2D), non-alcoholic fatty liver disease (NAFLD) is very common and has an increased risk of clinically significant liver disease. The use...
5.
Ferrari-Cestari M, Okano S, Patel P, Horsfall L, Keshvari S, Hume D, et al.
Dig Dis
. 2022 Nov;
41(3):439-446.
PMID: 36327947
Background: Non-alcoholic fatty liver disease (NAFLD) is caused by ectopic fat accumulation in the liver as a consequence of metabolic perturbations associated with obesity, type 2 diabetes, dyslipidemia, and insulin...
6.
Jones S, Tillin T, Williams S, Rapala A, Chaturvedi N, Hughes A
Front Physiol
. 2022 Jul;
13:919754.
PMID: 35874520
Measuring local haemodynamics in skeletal muscle has the potential to provide valuable insight into the oxygen delivery to tissue, especially during high demand situations such as exercise. The aim of...
7.
Mason S, Al Saikhan L, Jones S, James S, Murray-Smith H, Rapala A, et al.
Neuroimage
. 2022 May;
257:119302.
PMID: 35595200
There is an increasing body of evidence suggesting that vascular disease could contribute to cognitive decline and overt dementia. Of particular interest is atherosclerosis, as it is not only associated...
8.
Gracen L, Hayward K, Aikebuse M, Russell A, OBeirne J, McPhail S, et al.
BMC Health Serv Res
. 2022 Apr;
22(1):487.
PMID: 35413987
Background: Non-alcoholic fatty liver disease (NAFLD) is an emerging epidemic that affects approximately half of all people with type 2 diabetes. Those with type 2 diabetes are a high-risk NAFLD...
9.
Williams S, Keogh S, Herd D, Riggall S, Glass R, Douglas C
BMC Health Serv Res
. 2022 Mar;
22(1):330.
PMID: 35279137
Background: Pain is a central and distressing experience for children in the emergency department (ED). Despite the harmful effects of pain, ED care often falls short of providing timely and...
10.
Gracen L, Hayward K, Aikebuse M, Williams S, Russell A, OBeirne J, et al.
Diabet Med
. 2022 Jan;
39(6):e14799.
PMID: 35100462
Aims: We explored barriers and facilitators to the implementation of nonalcoholic fatty liver disease (NAFLD) pathway for people with diabetes to identify determinants of behaviour surrounding the diagnosis, assessment and...